Guatemala receives the expected batch of Pfizer vaccines against COVID-19

After several changes to the entry date, the shipment will allow the continued immunization of minors aged 12-17, who are practically paralyzed throughout the country due to the lack of this biological.

Last Monday, the president of Mspas, Francisco Coma, apologized for the delay in the arrival of this direct purchase through the UN’s Covax mechanism, as the government had created high expectations with the date due to the persistent claim of parents who were unable to do so. To vaccinate their children despite tagging in long lines from the day before.

According to official information, it is expected that one million additional doses will be received from the same medical home in December, which will allow coverage of the target school population to return to face-to-face classes in basic and university education in February 2022.

Mspas registered nine million 382 thousand 724 vaccinated Guatemalans as of yesterday, of whom five million 644 thousand 27 with the injection and three million 738 thousand 697 with the full scheme.

Currently, Salud applies vaccines from pharmaceutical companies Moderna, Sputnik V, Pfizer and AstraZeneca, most of which are from donations.

Phase IV National Immunization Scheme, which covers people over 12 years of age.

In the near future, the government hopes from now on to reach children aged six to 11, as well as to boost a third dose of frontline workers to care for the COVID-19 pandemic.

memory / mm

Leave a Reply

Your email address will not be published. Required fields are marked *